2 March 2007
Tony Blair has said that "now is the moment for a big push" in improving the environment for the UK biotech industry.
Speaking prior to a meeting with biotech business leaders today, he said he would like to help before he leaves office later this year.
"To allow the biotech industry to get some strength in research out of the NHS is something we need to look at in this country.
"The fact that we can get the best people in from around the world to work in the UK is another enormous strength."
The UK accounts for just under half of public biotech companies in Europe, and has three times more than that of its nearest rival Germany.
Representatives from Astra Zeneca, Pfizer, GlaxoSmithkline, Amgen, and other firms were at Amgen’s new European HQ in Uxbridge to discuss how to maintain the UK’s competitive edge in the biotech and pharmaceutical industries.
"I’m here to listen," he said.
"We need to get the policy right so I need to know what you want me to do."
The Prime Minister added that he believes that the industry and Government have curbed the actions of animal rights extremists, and also underlined his support for stem cell research.
The discussions covered the cost of clinical trials, strengthening links with universities and funding.
The PM also announced that he will ask Sir David Cooksey to review progress on his 2003 report on the future challenges for biotech.
The Government believes it is vital that public support is maintained as biotechnology evolves - so any changes to the rules on stem cells will be scrutinised by Parliament.